focus -WSS

focus

author：entertainment 2025-09-05 11:31:18 - browse：2

Adam's take main illustration — Molly Ferguson/STAT

Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics:

A take-under deal feels meh for biotech sector sentiment.Bristol is paying $58 per share in cash for Mirati, which closed Friday at $60. Granted, Mirati was trading in the $30 range in September, so from there, the roughly 50% premium isn’t terrible. But as Mizuho strategist Jared Holz pointed out, investors would liked to have seen Mirati go for $75-$100 per share.

With the closely watched XBI biotech index down 13% for the year, every M&A deal helps improve sentiment, but this one — maybe just a little. Bristol is paying $4.8 billion in cash to acquire Mirati, or $3.7 billion after accounting for Mirati’s cash. It’s a small bolt-on acquisition for Bristol, which isn’t overpaying.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Why the advice to take all your antibiotics may be wrong

WSS

What is artificial intelligence? Experts weigh in

How the first Native Hawaiian psychiatrist helped diversify medicine

A new deal aims to ramp up use of AI in rehab care decisions

What is artificial intelligence? Experts weigh in

It's time to take a new tack for treating Alzheimer's

FDA greenlights medical device to combat bladder issues

knowledge

focus

entertainment

Walensky prepares to leave CDC — and Congress — behind

A new deal aims to ramp up use of AI in rehab care decisions

Alkermes shareholders re

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

'The View' co

Medical records are filled with copy

Why the advice to take all your antibiotics may be wrong

Bright Health sells Medicare Advantage business to Molina

California store owner shot dead in dispute over displaying Pride flag: Police

hotspot

How the first Native Hawaiian psychiatrist helped diversify medicine

CDC says it’s too soon to assess risk posed by Covid subvariant

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Why the advice to take all your antibiotics may be wrong

EMA weighs against approval for Mirati's lung cancer drug

CDC says it’s too soon to assess risk posed by Covid subvariant

explore

hotspot

focus

explore